EUVIMEDEUVIMED entdecken
Systematische Übersicht

Acute Rejection Rates in Vascularized Composite Allografts: A Systematic Review of Case Reports

Loïc Van Dieren, Pierre Tawa, Marie Coppens, Laura Naenen, Omer Dogan, Tom Quisenaerts, Hyshem H Lancia, Haïzam Oubari, Yohann Dabi, Maxime De Fré, Filip Thiessen Ef, Curtis L Cetrulo und 1 weitere

Journal of Surgical Research · 2024-06 · 298 · 137-148

DOI: 10.1016/j.jss.2024.02.019 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Surgical Research, 2024-06. Verfasst von Loïc Van Dieren und 12 weiteren Autor:innen. Beteiligte Einrichtung: Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, B…. Hauptthemen laut MEDLINE: Graft Rejection, Composite Tissue Allografts, Immunosuppressive Agents, Vascularized Composite Allotransplantation. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 182 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Vascularized Composite Allografts (VCA) are usually performed in a full major histocompatibility complex mismatch setting, with a risk of acute rejection depending on factors such as the type of immunosuppression therapy and the quality of graft preservation. In this systematic review, we present the different immunosuppression protocols used in VCA and point out relationships between acute rejection rates and possible factors that might influence it. METHODS: This systematic review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. We systematically searched Medline (PubMed), Embase, and The Cochrane Library between November 2022 and February 2023, using following Mesh Terms: Transplant, Transplantation, Hand, Face, Uterus, Penis, Abdominal Wall, Larynx, and Composite Tissue Allografts. All VCA case reports and reviews describing multiple case reports were included. RESULTS: We discovered 211 VCA cases reported. The preferred treatment was a combination of antithymocyte globulins, mycophenolate mofetil (MMF), tacrolimus, and steroids; and a combination of MMF, tacrolimus, and steroids for induction and maintenance treatment, respectively. Burn patients showed a higher acute rejection rate (P = 0.073) and were administered higher MMF doses (P = 0.020). CONCLUSIONS: In contrast to previous statements, the field of VCA is not rapidly evolving, as it has encountered challenges in addressing immune-related concerns. This is highlighted by the absence of a standardized immunosuppression regimen. Consequently, more substantial data are required to draw more conclusive results regarding the immunogenicity of VCAs and the potential superiority of one immunosuppressive treatment over another. Future efforts should be made to report the VCA surgeries comprehensively, and muti-institutional long-term prospective follow-up studies should be performed to compare the number of acute rejections with influencing factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionComposite Tissue AllograftsImmunosuppressive AgentsVascularized Composite AllotransplantationHumansImmunosuppression TherapyAcute Disease

Stichwörter der Autor:innen

Acute rejectionConservation solutionImmunosuppressive regimensVascularized composite allografts

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Faculty of Medicine and Health Sciences, Antwerp…
  • Vascularized Composite Allotransplantation Laboratory, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Division of Plastic and Reconstructive Surgery,…
  • Faculty of Medicine and Health Sciences, Antwerp, Belgium.
  • Department of Obstetrics, Gynecology and Reproductive Medicine, Sorbonne University, Tenon Hospital (AP-HP), Paris, France.
  • Department of Plastic, Reconstructive and Aesthetic Surgery, Antwerp University Hospital, Antwerp, Belgium.

Zitieren

APA

Van Dieren, L., Tawa, P., Coppens, M., Naenen, L., Dogan, O., Quisenaerts, T., Lancia, H. H., Oubari, H., Dabi, Y., De Fré, M., Thiessen Ef, F., Cetrulo, C. L., & Lellouch, A. G. (2024). Acute Rejection Rates in Vascularized Composite Allografts: A Systematic Review of Case Reports. Journal of Surgical Research, 298, 137-148. https://doi.org/10.1016/j.jss.2024.02.019

Vancouver

Van Dieren L, Tawa P, Coppens M, Naenen L, Dogan O, Quisenaerts T, et al. Acute Rejection Rates in Vascularized Composite Allografts: A Systematic Review of Case Reports. Journal of Surgical Research. 2024;298:137-148. doi:10.1016/j.jss.2024.02.019

BibTeX
@article{VanDieren2024,
  author = {Van Dieren, Loïc and Tawa, Pierre and Coppens, Marie and Naenen, Laura and Dogan, Omer and Quisenaerts, Tom and Lancia, Hyshem H and Oubari, Haïzam and Dabi, Yohann and De Fré, Maxime and Thiessen Ef, Filip and Cetrulo, Curtis L and Lellouch, Alexandre G},
  title = {Acute Rejection Rates in Vascularized Composite Allografts: A Systematic Review of Case Reports},
  journal = {Journal of Surgical Research},
  year = {2024},
  volume = {298},
  pages = {137--148},
  doi = {10.1016/j.jss.2024.02.019}
}
Kostenlos starten →